Literature DB >> 3759648

Isolation and structural identification of nine avilamycins.

J L Mertz, J S Peloso, B J Barker, G E Babbitt, J L Occolowitz, V L Simson, R M Kline.   

Abstract

Avilamycin is an antibiotic complex produced by cultures of the organism Streptomyces viridochromogenes, strain NRRL 2860. These compounds belong to the orthosomycin family of antibiotics. Structural composition of the major avilamycins and several minor avilamycins are known. Nine additional minor avilamycins, designated F through N, have been isolated via semi-preparative silica gel or reverse-phase high performance liquid chromatography with final purification using a reverse-phase column loading solvent switching technique. 1H NMR and mass spectroscopy, negative ion fast atom bombardment (neg FAB) and electron impact, were used to structurally identify the avilamycins. All of the compounds were microbiologically active and similar in structure to other known avilamycins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759648     DOI: 10.7164/antibiotics.39.877

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Avilamycin and evernimicin induce structural changes in rProteins uL16 and CTC that enhance the inhibition of A-site tRNA binding.

Authors:  Miri Krupkin; Itai Wekselman; Donna Matzov; Zohar Eyal; Yael Diskin Posner; Haim Rozenberg; Ella Zimmerman; Anat Bashan; Ada Yonath
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-19       Impact factor: 11.205

3.  Cloning of an avilamycin biosynthetic gene cluster from Streptomyces viridochromogenes Tü57.

Authors:  S Gaisser; A Trefzer; S Stockert; A Kirschning; A Bechthold
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

Review 4.  Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.

Authors:  Patrick Butaye; Luc A Devriese; Freddy Haesebrouck
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 5.  Bioactive oligosaccharide natural products.

Authors:  Emilianne K McCranie; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2014-08       Impact factor: 13.423

6.  Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study.

Authors:  Anxiong Huang; Xun Luo; Zihui Xu; Lingli Huang; Xu Wang; Shuyu Xie; Yuanhu Pan; Shiwei Fang; Zhenli Liu; Zonghui Yuan; Haihong Hao
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

Review 7.  Microbial Oligosaccharides with Biomedical Applications.

Authors:  Jian-Lin Xu; Zhi-Feng Liu; Xiao-Wei Zhang; Hai-Li Liu; Yong Wang
Journal:  Mar Drugs       Date:  2021-06-21       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.